Biorevitalisation
SUNEKOS references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
CE Marked
SKU 13756
Sunekos Cell 15
Sunekos Cell 15 is an effective solution that targets Edematous Fibrosclerotic Panniculopathy (EFP) in stages I–IV. It restructures the extracellular matrix to improve microcirculation and reduce fibrosis.
In stock
Laboratory
Professional Dietetics S.p.A.
Origin
Italien
Indication
Cellulite, EFP, stages I to IV
Treatment areas
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.
Sunekos Cell 15 is an injectable cellulite treatment by Sunekos, developed around the extracellular matrix rather than the fat cell. It is used to treat cellulite, framed as Edematous Fibrosclerotic Panniculopathy, across stages I to IV. The product is based on a synergy of hyaluronic acid, amino acids and an alkaline solution in a non-lipoclastic, non-lipolytic approach, and is intended for professional use by qualified practitioners.
Key Benefits of Sunekos Cell 15
- CE-marked Class III medical device
- Promotes optimisation of extracellular matrix protein turnover
- Supports neo-collagenesis rather than collagenase
- Helps improve microcirculation
- Helps reduce fibrosis by re-equilibrating extracellular matrix inflammation
- Helps regulate physiological pH
- Non-invasive, non-lipoclastic and non-lipolytic approach focused on restructuring the extracellular matrix
- Supported by a preliminary study on 25 subjects reporting a reduction in clinical evaluation score in both cellulite stage groups
Indications and Professional Use
Main indications
- Cellulite, framed as Edematous Fibrosclerotic Panniculopathy (EFP)
- Cellulite stages I and II
- Cellulite stages III and IV
- Fibrosis and extracellular matrix inflammation associated with cellulite
- Impaired microcirculation associated with cellulite
Professional use
Sunekos Cell 15 is a CE-marked Class III medical device intended for medical-practitioner use only. It is supplied as a two-component treatment pack that is reconstituted before use, combining low-molecular-weight sodium hyaluronate and amino acids with carbonate/bicarbonate salts.
Treatment areas
- Cellulite-affected areas of the thighs and gluteal/trochanteric region
Patient profile
Sunekos Cell 15 is intended for adult patients presenting with cellulite / Edematous Fibrosclerotic Panniculopathy (EFP), including stages I–IV. A preliminary clinical evaluation included 25 subjects, with 11 in stages I–II and 14 in stages III–IV.
How Sunekos Cell 15 Works
Sunekos Cell 15 works through a synergy of hyaluronic acid, amino acids and an alkaline solution. Where earlier intradermal approaches to cellulite mainly addressed edema and microcirculation, this combination also targets the extracellular matrix: it is designed to optimise extracellular matrix protein turnover, improve microcirculation, reduce fibrosis by re-equilibrating matrix inflammation and help regulate physiological pH. The approach is non-lipoclastic and non-lipolytic, rebuilding rather than destroying, which makes it suitable for restoring skin and adipose tissue homeostasis rather than breaking down fat.
Why Order From Allpara
Allpara offers genuine, verified SUNEKOS products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
Which cellulite stages does Sunekos Cell 15 treat?
Sunekos Cell 15 shows indications for cellulite stages I and II and for stages III and IV, with staging determined by the treating practitioner before treatment.
How does Sunekos Cell 15 differ from lipolytic cellulite treatments?
Sunekos Cell 15 is a non-lipoclastic and non-lipolytic approach. Instead of breaking down fat, it restructures the extracellular matrix, an approach of rebuilding rather than destroying.
Why does Sunekos Cell 15 include an alkaline solution?
The alkaline solution is part of the synergy that helps regulate physiological pH and re-equilibrate extracellular matrix inflammation, which helps reduce the fibrosis component of cellulite.
More from Professional Dietetics
Skin Boosters
Clinic alternatives
Mesotherapy
/ Recently viewed
Pick up where you left off
Sunekos Cell 15
In stock
CE Marked
Sunekos Cell 15 is an injectable cellulite treatment by Sunekos, developed around the extracellular matrix rather than the fat cell. It is used to treat cellulite, framed as Edematous Fibrosclerotic Panniculopathy, across stages I to IV. The product is based on a synergy of hyaluronic acid, amino acids and an alkaline solution in a non-lipoclastic, non-lipolytic approach, and is intended for professional use by qualified practitioners.
Key Benefits of Sunekos Cell 15
- CE-marked Class III medical device
- Promotes optimisation of extracellular matrix protein turnover
- Supports neo-collagenesis rather than collagenase
- Helps improve microcirculation
- Helps reduce fibrosis by re-equilibrating extracellular matrix inflammation
- Helps regulate physiological pH
- Non-invasive, non-lipoclastic and non-lipolytic approach focused on restructuring the extracellular matrix
- Supported by a preliminary study on 25 subjects reporting a reduction in clinical evaluation score in both cellulite stage groups
Indications and Professional Use
Main indications
- Cellulite, framed as Edematous Fibrosclerotic Panniculopathy (EFP)
- Cellulite stages I and II
- Cellulite stages III and IV
- Fibrosis and extracellular matrix inflammation associated with cellulite
- Impaired microcirculation associated with cellulite
Professional use
Sunekos Cell 15 is a CE-marked Class III medical device intended for medical-practitioner use only. It is supplied as a two-component treatment pack that is reconstituted before use, combining low-molecular-weight sodium hyaluronate and amino acids with carbonate/bicarbonate salts.
Treatment areas
- Cellulite-affected areas of the thighs and gluteal/trochanteric region
Patient profile
Sunekos Cell 15 is intended for adult patients presenting with cellulite / Edematous Fibrosclerotic Panniculopathy (EFP), including stages I–IV. A preliminary clinical evaluation included 25 subjects, with 11 in stages I–II and 14 in stages III–IV.
How Sunekos Cell 15 Works
Sunekos Cell 15 works through a synergy of hyaluronic acid, amino acids and an alkaline solution. Where earlier intradermal approaches to cellulite mainly addressed edema and microcirculation, this combination also targets the extracellular matrix: it is designed to optimise extracellular matrix protein turnover, improve microcirculation, reduce fibrosis by re-equilibrating matrix inflammation and help regulate physiological pH. The approach is non-lipoclastic and non-lipolytic, rebuilding rather than destroying, which makes it suitable for restoring skin and adipose tissue homeostasis rather than breaking down fat.
Why Order From Allpara
Allpara offers genuine, verified SUNEKOS products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
Which cellulite stages does Sunekos Cell 15 treat?
Sunekos Cell 15 shows indications for cellulite stages I and II and for stages III and IV, with staging determined by the treating practitioner before treatment.
How does Sunekos Cell 15 differ from lipolytic cellulite treatments?
Sunekos Cell 15 is a non-lipoclastic and non-lipolytic approach. Instead of breaking down fat, it restructures the extracellular matrix, an approach of rebuilding rather than destroying.
Why does Sunekos Cell 15 include an alkaline solution?
The alkaline solution is part of the synergy that helps regulate physiological pH and re-equilibrate extracellular matrix inflammation, which helps reduce the fibrosis component of cellulite.
More from Professional Dietetics
View laboratory →* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.